Status:
UNKNOWN
Acute CorPulmonale and ARDS Circulation Protection China Study China (ACPC)
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
ARDS (Acute Respiratory Distress Syndrome)
Acute Cor Pulmonale
Eligibility:
All Genders
18-85 years
Brief Summary
The investigators established a national cohort of Chinese ARDS with Acute CorPulmonale to enable prospective observational studies. The goals are the following. First, morbidity and mortality rate o...
Detailed Description
Acute respiratory distress syndrome (ARDS) is an acute and critical illness characterized by progressive dyspnea and refractory hypoxemia caused by intrapulmonary or extrapulmonary factors. The mortal...
Eligibility Criteria
Inclusion
- 18≤ aged ≤85 years old
- received a diagnosis of ARDS with Acute CorPulmonal
- provided signed informed consent
Exclusion
- are diagnosed as cardiogenic pulmonary edema
- are diagnosed as Idiopathic pulmonary fibrosis acute exacerbation
- are participating in other interventional clinical trials
- refused to continue to participate in the study or refused further treatment
- unable to complete the study procedure even if assisted and otherwise unable to comply with the study protocol
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03827863
Start Date
April 1 2019
End Date
March 31 2020
Last Update
February 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, China, 100730